A carregar...
Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?
PURPOSE: Methotrexate (MTX) is the first choice conventional disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis. It is not universally effective, however; although to date it is not possible to predict with any accuracy which patients will respond to treatment. The aim of this ana...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2596302/ https://ncbi.nlm.nih.gov/pubmed/18292102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2008.088237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|